Natural Products Derived from Traditional Chinese Medicine as Novel Inhibitors of the Epidermal Growth Factor Receptor
Journal:
Combinatorial Chemistry & High Throughput Screening
Volume:
13
Page:
849-854
Author(s):
Serkan Sertel, Peter K. Plinkert and Thomas Efferth
Heme Oxygenase-1 in Tumor Biology and Therapy
Journal:
Current Drug Targets
Volume:
11
Page:
1551-1570
Author(s):
Halina Was, Jozef Dulak and Alicja Jozkowicz
Recent Innovations in Antibody-Mediated, Targeted Particulate Nanotechnology and Implications for Advanced Visualisation and Drug Delivery
Journal:
Current Nanoscience
Volume:
6
Page:
560-570
Author(s):
Francois Fay, Christopher J. Scott and Paul A. McCarron
Use of Mathematical Structural Invariants in Analyzing Combinatorial Libraries: A Case Study with Psoralen Derivatives
Journal:
Current Computer-Aided Drug Design
Volume:
6
Page:
240-251
Author(s):
Subhash C. Basak, Denise Mills, Brian D. Gute, Alexandru T. Balaban, Kanika Basak and Gregory D. Grunwald
Predictive Molecular Markers of Response to Epidermal Growth Factor Receptor(EGFR) Family-Targeted Therapies
Journal:
Current Cancer Drug Targets
Volume:
10
Page:
799-812
Author(s):
Sarah Barton, Naureen Starling and Charles Swanton
KRAS Mutation Testing of Colorectal Cancer for Anti-EGFR Therapy: Dogmas Versus Evidence
Journal:
Current Cancer Drug Targets
Volume:
10
Page:
813-823
Author(s):
J. Timar, B. Hegedus and E. Raso
Strategies for Overcoming Inherent and Acquired Resistance to EGFR Inhibitors by Targeting Downstream Effectors in the RAS/PI3K Pathway
Journal:
Current Cancer Drug Targets
Volume:
10
Page:
824-833
Author(s):
A. J. Weickhardt, N. C. Tebbutt and J. M. Mariadason
Targeting Ras-RAF-ERK and its Interactive Pathways as a Novel Therapy for Malignant Gliomas
Journal:
Current Cancer Drug Targets
Volume:
10
Page:
840-848
Author(s):
H.-W. Lo
The Crosstalk of RAS with the TGF-β Family During Carcinoma Progression and its Implications for Targeted Cancer Therapy
Journal:
Current Cancer Drug Targets
Volume:
10
Page:
849-857
Author(s):
M. Grusch, M. Petz, T. Metzner, D. Ozturk, D. Schneller and W. Mikulits
Implication of Heat Shock Protein 90 (HSP90) in Tumor Angiogenesis: A Molecular Target for Anti-Angiogenic Therapy?
Journal:
Current Cancer Drug Targets
Volume:
10
Page:
890-897
Author(s):
K. Staufer and O. Stoeltzing